Skip to main content

Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity

Publications

RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation

Author(s): Guillermo Yoldi, Pasquale Pellegrini, Eva M. Trinidad, Alex Cordero, Jorge Gomez-Miragaya, Jordi Serra-Musach, William C. Dougall, Purificación Muñoz, Miguel-Angel Pujana, Lourdes Planelles, Eva González-Suárez
Published in: Cancer Research, Issue 76/19, 2016, Page(s) 5857-5869, ISSN 0008-5472
DOI: 10.1158/0008-5472.can-15-2745

RANKL inhibitors for osteosarcoma treatment: hope and caution

Author(s): Eva M. Trinidad, Eva González-Suárez
Published in: Annals of Translational Medicine, Issue 4/24, 2016, Page(s) 534-534, ISSN 2305-5839
DOI: 10.21037/atm.2016.12.10

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

Author(s): Roger von Moos, Luis Costa, Eva Gonzalez-Suarez, Evangelos Terpos, Daniela Niepel, Jean–Jacques Body
Published in: Cancer Treatment Reviews, 2019, ISSN 0305-7372
DOI: 10.1016/j.ctrv.2019.05.003

Interrogating open issues in cancer precision medicine with patient-derived xenografts

Author(s): Annette T. Byrne, Denis G. Alférez, Frédéric Amant, Daniela Annibali, Joaquín Arribas, Andrew V. Biankin, Alejandra Bruna, Eva Budinská, Carlos Caldas, David K. Chang, Robert B. Clarke, Hans Clevers, George Coukos, Virginie Dangles-Marie, S. Gail Eckhardt, Eva Gonzalez-Suarez, Els Hermans, Manuel Hidalgo, Monika A. Jarzabek, Steven de Jong, Jos Jonkers, Kristel Kemper, Luisa Lanfrancone, Gunh
Published in: Nature Reviews Cancer, Issue 17/4, 2017, Page(s) 254-268, ISSN 1474-175X
DOI: 10.1038/nrc.2016.140

European Network of Breast Development and Cancer turned 10 years: a growing family of mammary gland researchers

Author(s): Zuzana Koledova, Beatrice A. Howard, Johanna Englund, Karsten Bach, Mohammed Bentires-Alj, Eva Gonzalez-Suarez
Published in: Breast Cancer Research, Issue 20/1, 2018, ISSN 1465-542X
DOI: 10.1186/s13058-018-1032-9